AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 1:136-142, May 1993
© 1993 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sweet, R. A.
Right arrow Articles by Zubenko, G. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sweet, R. A.
Right arrow Articles by Zubenko, G. S.

REGULAR ARTICLE

Phenomenology and Prevalence of Neuroleptic-Induced Akathisia in Late Life

Robert A. Sweet, M.D., Benoit H. Mulsant, M.D., Mark E. Kunik, M.D., A. Hind Rifai, M.D., Rona E. Pasternak, M.D., Jules Rosen, M.D., and George S. Zubenko, M.D., Ph.D.

Geriatric Health Services, Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA; and the Department of Psychiatry, Baylor College of Medicine, Houston, TX.

The authors examined 115 patients totaling 127 admissions to an acute care geriatric psychiatry inpatient unit using the Barnes Akathisia Scale. Subjective complaints of akathisia were associated with a diagnosis of major depression and correlated with Hamilton Rating Scale for Depression scores but were not associated with current neuroleptic treatment. Objective evidence of akathisia was strongly associated with current neuroleptic use. Patients from 45 admissions were receiving neuroleptics at the time of assessment. By using the presence of objective akathisia to define the syndrome, the authors identified 8 patients from these 45 (17.8%) as having neuroleptic-induced akathisia (NIA). The presence of NIA was associated with a lower rate of antiparkinsonian agent use. NIA contributed to the presenting complaints on admission in 7patients, comprising 5.5% of all 127 admissions.




This article has been cited by other articles:


Home page
AJGPHome page
D. C. Mamo, B. G. Pollock, B. Mulsant, P. R. Houck, S. Bensasi, M. C. Miller, M. S. Redfern, and C. F. Reynolds III
Effects of Nortriptyline and Paroxetine on Postural Sway in Depressed Elderly Patients
Am J Geriatr Psychiatry, April 1, 2002; 10(2): 199 - 205.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
D. C. Mamo, R. A. Sweet, B. H. Mulsant, B. G. Pollock, M. D. Miller, J. A. Stack, A. E. Begley, and C. F. Reynolds III
Effect of Nortriptyline and Paroxetine on Extrapyramidal Signs and Symptoms: A Prospective Double-Blind Study in Depressed Elderly Patients
Am J Geriatr Psychiatry, August 1, 2000; 8(3): 226 - 231.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 1993 American Association for Geriatric Psychiatry